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ABSTRACT Amyloid-associated diseases affect millions of people worldwide. Phenol red exhibits modest inhibition toward
ﬁbril formation of human Islet amyloid polypeptide (hIAPP) and its toxicity, which is associated with type II diabetes mellitus.
However, the molecular level mechanisms of interactions remain elusive. The binding of phenol red molecules to the protoﬁbrils
of an amyloidogenic fragment (NFGAIL) of hIAPP has been investigated by molecular dynamics simulations with explicit
solvent. The phenol red molecules were observed to bind primarily along either b-sheet stacking or b-strand directions. Through
its three aromatic rings, the phenol red molecule preferentially interacted with the hydrophobic side chains of Phe, Leu, and Ile;
and the polar sulfone and hydroxyl groups were mainly exposed in solvent. Thus, phenol red improves the solubility of the early
protoﬁbrils and represses further growth. Interestingly, there was no obvious preference toward the aromatic Phe residue in
comparison to the hydrophobic Leu or Ile residues. The lack of binding along the hydrogen bond direction indicates that phenol
red does not directly block the b-sheet extension. Further free energy analysis suggested that a phenol red analog may
potentially improve the binding afﬁnity.
INTRODUCTION
A number of human diseases including type II diabetes
and neurodegenerative diseases such as Alzheimer’s, prion,
Parkinson’s, and Huntington’s diseases (1–4) have been
associated with a common pathological process. These dis-
eases affect a large human population worldwide with no
effective treatment at present. For instance, type II diabetes
alone affects more than 150 million people worldwide and
the number is growing (5). In all these diseases, deposition of
amyloid plaques of different proteins is found in different
parts of the human body such as brain and pancreas (1–4).
The observation that synthetic amyloid aggregates are toxic
to the corresponding cells such as nerve cell (6) and b-islet
cell (7) suggests that amyloid aggregation might be related to
the diseases. Although the exact pathogenic species have not
been identiﬁed, amyloid ﬁbrils and the protoﬁbrillar species
(soluble oligomers and protoﬁbrils) are considered the
primary sources of toxicity (8–10).
There are two main classes of inhibitors against amy-
loidogenicity and cytotoxicity. The ﬁrst class consists of
short synthetic peptides from the core fragments of amyloid
peptides with chemical modiﬁcations (11–15). Although the
main part of the peptides may be involved in binding to
amyloid target via both main-chain hydrogen bonds and
speciﬁc side-chain recognition, the chemical asymmetrical
modiﬁcations remove the amide hydrogen bonds and inhibit
the amyloid ﬁbril growth. The second class consists of small
aromatic molecules, such as Congo red, acridine orange,
rifampin, tannic acid, and ferulic acid (16–24). Several
inhibition mechanisms for the second class have been
proposed, including stabilization of the monomeric states to
inhibit unfolding, stabilization of early small protoﬁbrils to
prevent growth of amyloid ﬁbrils, and destabilization of
amyloid ﬁbrils.
Human islet amyloid polypeptide (hIAPP), a 37-amino-
acid hormone, is the main constituent of the islet amyloid
ﬁbrils deposited in pancreas in 95% of type II diabetes
mellitus (25,26). It has been established that hIAPP forms
amyloid ﬁbrils (27) in vitro which induces islet b-cell apo-
ptosis (7). Recently, its soluble oligomer and protoﬁbril have
been suggested to be cytotoxic (28–30). The hexapeptide
NFGAIL, a fragment truncated from hIAPP (residues 22–
27), is one of the shortest fragments that have been shown to
form amyloid ﬁbrils similar to those formed by the full
polypeptide (31) and the ﬁbrils are cytotoxic toward the pan-
creatic cell line. Therefore, this hIAPP ‘‘amyloid-core’’ pep-
tide has been used as a simpliﬁed model system to facilitate
the discovery of key factors underlying amyloid ﬁbril for-
mation and the development of antiamyloid agents.
Alanine-scanning mutagenesis revealed that the Phe res-
idue plays a critical role in the formation of the ﬁbrils (32).
This led Gazit and co-workers (14) to search for aromatic
compounds to interact with Phe to inhibit the hIAPP amyloid
formation and its cytotoxicity. Among the aromatic com-
pounds, phenol red has shown moderate inhibition activity
against the hIAPP ﬁbril formation and the cytotoxicity
toward pancreatic b-cells. Since phenol red has been used for
many years as a diagnostic agent in kidney disease and as a
weak estrogen (33), its toxicity has been well characterized.
It was suggested (14) that the inhibition was due to the
heteroaromatic interaction and, hence, interaction with Phe
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residue was thought to play crucial roles. Despite this prog-
ress, because the inhibitor-protoﬁbril complexes are hetero-
geneous, high resolution structure of the complex is
unavailable, hindering the effort to understand the detailed
molecular level mechanisms of the interactions between the
small molecule inhibitors and the early aggregation species.
Furthermore, the needed high drug/hIAPP molar ratio to
inhibit the hIAPP1-37 ﬁbril formation (14) may prevent it
from being a viable therapeutic agent for type II diabetes.
Thus, reﬁnement to improve its potency may be helpful.
In a series of simulation studies of the hexapeptide
NFGAIL, we employed all-atom molecular dynamics with
explicit solvent and particle mesh Ewald (34) method for the
treatment of long-range electrostatic forces to elucidate the
aggregation process from the formation of partially ordered
tetramers (35) to the formation of well-ordered octamers (36)
and dodecamer protoﬁbrils (37). We now take a step further
to study the interaction between phenol red and the dodecamer
protoﬁbrils and to examine modiﬁcations to improve its
binding afﬁnity.
METHOD
Systems
Three types of systems were simulated in this study, consisting of solutions
of protoﬁbril alone, of ligand alone, and of protoﬁbril and ligand together
(Table 1). In the simulations of protoﬁbril or ligand alone, no restraints were
applied. In the simulations of protoﬁbril and ligand together, the peptide
strands were restrained to the b-extended conformation by restraining the
main-chain torsion angles around (F  110,C  135) with a harmonic
potential and a restraining force constant of 5.0 kcal/mol/rad2. Because our
focus is on the ordered protoﬁbril, this measure reduces sampling of con-
formational space so that the key interactions between ordered protoﬁbril
and phenol red can be studied.
Phenol red comprises three aromatic rings and has both acidic and basic
forms (see Fig 4, A and B) with pKa of 7.4. Thus, the acidic form is the main
species (;90%) in the experiment (14) of Gazit and co-workers (pH 6.5). In
our simulations, we chose to focus on the acidic species. The interaction
between the basic form and protoﬁbril was postevaluated in the calculation
of the binding free energy by substituting the acidic form with the basic
form.
In the simulations of phenol red and protoﬁbril, each system consists of
four phenol red molecules in acidic form, a protoﬁbril, and water molecules.
The four phenol red molecules were initially placed 15 A˚ away from a
preformed 12-peptide protoﬁbril (37) at four corners of the plane perpen-
dicular to the b-sheet plane. They were then immersed into a triclinic box of
7165 water molecules, equivalent to a truncated-octahedral box with
dimensions of a ¼ b ¼ c ¼ 67.35 A˚, a ¼ b ¼ g ¼ 109.47. The periodic
water box was constructed such that the solute was at least 10 A˚ away from
the box surface and the minimum distance between solute and the image was
20 A˚. The effective concentrations of phenol red and the protoﬁbril were
;28 mM and ;7 mM, respectively. In comparison, the concentrations of
phenol red and peptides in the experiment of Gazit and co-workers were,
respectively, 40 mM and 4 mM14. High concentration (;1000 fold higher)
and high temperature (320 K) were used in the simulations to bypass the
slow diffusion step and to speed up the binding process. In addition, the
presence of four phenol red molecules in each simulation system allows
sampling of multiple phenol red conformations in a single trajectory and
enhances sampling in comparison to systems with a single phenol red
molecule.
The Duan et al. all-atom point-charge force ﬁeld (38) (Amber ff03) was
chosen to represent the peptide; and the N- and C-termini were blocked
respectively by acetyl (ACE) and amine groups (NHE). The partial charges
of the phenol red molecule were obtained by ﬁtting its gas-phase elec-
trostatic potential calculated at HF/6-31G* level of quantum mechanical
theory using RESP (39) in both acidic and basic forms (Fig. 4, A and B)
subjected to geometry optimization at the level of HF/6-31G*. The other
parameters of phenol red molecule were taken from the Amber GAFF (40)
parameter set. The solvent was explicitly represented by the TIP3P (41)
water model. To validate their force ﬁeld parameters, a simulation (10 ns)
was conducted on each form at 320 K. Their bond length and bond angles in
crystal form (42) were well maintained in the molecular dynamics simu-
lations (data not shown), and the torsion angles of the rotatable bonds were
well sampled as indicated by the sampling of a complete 360 (Fig. S2,
Supplementary Material).
Molecular dynamics simulation
The Amber simulation package was used in both molecular dynamics
simulations and data processing (43). The protoﬁbril-ligand-water system
was subjected to periodic boundary conditions via both minimum image and
discrete Fourier transform as part of the particle mesh Ewald method (34).
After the initial energy minimization, two simulation runs for each system
were performed starting from the same coordinates but with different initial
random velocities by choosing different random number seeds. The initial
velocities were generated according to the Boltzmann’s distribution at
500 K. The simulations started from a 10.0-ps run at 500 K to randomize
the orientations and positions of the four phenol red molecules. A short 1.0-ns
molecular dynamics at 320 K in the NPT ensemble (constant number of
atoms in the box, constant pressure and temperature) was performed to
adjust system size and density and to equilibrate the solvent. The simulations
were continued at 320 K for 19 ns in the NVT ensemble (constant number of
atoms in the box, constant volume, and constant temperature). The particle
mesh Ewald method (34) was used to treat the long-range electrostatic
interactions. SHAKE (44) was applied to constrain all bonds connecting
hydrogen atoms, and a time step of 2.0 fs was used. To reduce the
computation, nonbonded forces (van der Waals and electrostatic forces)
were calculated using a standard two-stage RESPA approach (45) where the
forces within a 10-A˚ radius were updated every step and those beyond 10 A˚
were updated every two steps. Temperature was controlled at 320 K by using
Berendsen’s algorithm (46) with a coupling constant of 2.0 ps. The center of
mass translation and rotation were removed every 500 steps. Studies have
shown this removes the ‘‘block of ice’’ problem (47,48). The trajectories
were saved at 2.0-ps intervals for further analysis. The same protocol was
used in the simulation of the ligand and protoﬁbril alone system, except that
the heating step at 500 K was skipped.
TABLE 1 Summary of simulated systems
ID Content
No. of
water
molecules
Box*
size (A˚)
Concentration
(mM)
No.
of
simulations
Length
of
each
1 Protoﬁbril11PRy 7165 67.4 7.0 2 20 ns
2 Protoﬁbril21PR 7165 67.4 7.0 2 20 ns
3 Protoﬁbril31PR 7165 67.4 7.0 2 20 ns
4 Protoﬁbril 1 2965 50.8 16.5 1 10 ns
5 Protoﬁbril 2 2965 50.8 16.5 1 10 ns
6 Protoﬁbril 3 2965 50.8 16.5 1 10 ns
7 PR, acidic 788 31.9 42.0 1 10 ns
8 PR, basic 788 31.9 42.0 1 10 ns
*Triclinic box equivalent to the true truncated octahedral box.
yPR, phenol red.
Na1 is added to neutralize the charge of basic form (Fig. 4).
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Binding free energies
The binding free energies of phenol red and an analog were evaluated on the
representative structures of the populated complex clusters from the protoﬁbril-
ligand simulations using the MM-GBSA (molecular mechanics-generalized
Born/surface area) approach (49). The solvation free energy was represented
by a combination of the GBSA method using the GBSA module in the Amber
package. The phenol red analog (3H-2,1-benzoxathiole, 3,3-diphenyl-, 1,1-
dioxide) is generated by substituting the phenol rings of phenol red molecule
with benzene rings. The force ﬁeld parameters of the analog were obtained by
following the same protocol as that of phenol red. The complex free energies
were evaluated after 2000 steps of energy minimization.
RESULTS
Three representative protoﬁbrils were selected in this study
from a pool of about eight ordered aggregates produced in an
earlier study (37). They are hereafter referred to as ‘‘proto-
ﬁbrils 1–3’’ as illustrated in Fig. S1 (SupplementaryMaterial).
To test their stability, simulations (10 ns each) without any
restraints were conducted at 320 K. At the end of the sim-
ulations, minor changes of the protoﬁbril were observed, as
expected under thermal ﬂuctuation. For example, some pep-
tides located at the ends of the b-sheets changed to coil; two
ending peptides of the middle layer in protoﬁbril 3 moved to
the upper layer (supplemental Fig. S1). However, the three-
layer architecture of the protoﬁbrils was well maintained and
the majority of peptides were still in b-sheet conformation.
Because we intend to study the interaction between the phe-
nol red and the ordered protoﬁbrils, we chose to restrain the
peptides to the extended conformation in protoﬁbril1 ligand
simulations. However, the interpeptide distances were not re-
strained. Nevertheless, the restraints prevented phenol red
from inducing conformational changes of peptides.
For each of the three protoﬁbril oligomers, starting from a
12-peptide protoﬁbril in three-layer b-sheet conﬁguration,
four phenol red molecules were placed 15 A˚ away from the
protoﬁbril (e.g., see Fig. 3) that were separated by water mol-
ecules, allowing simultaneous sampling of multiple phenol
red conformations in a single simulation trajectory. Two in-
dependent simulation runs (20 ns each) were conducted for
each of the three systems. Thus, the six simulations allowed
us to sample 24 phenol red conformations simultaneously.
We examined the conformations of the phenol red molecules
in both the free and the bound forms in the complex
simulations and compared to those in the ligand simulations.
The fact that all four rotatable dihedral angles completely
sampled the entire 360 suggests a reasonable sampling
(supplemental Fig. S2). After binding to protoﬁbril, the
phenol red became slightly more rigid, indicated by some-
what restricted sampling of its torsion angles 3 and 4
(supplemental Fig. S2). The close resemblance of the torsion
angle distributions to those in the free ligand simulation is
indicative of a good sampling in the bound state.
In the presence of phenol red, the overall structures of the
three protoﬁbril oligomers were well maintained in the sim-
ulations with restraints. For protoﬁbrils 1 and 2, the main-
chain heavy atom RMSD of the protoﬁbrils relative to their
initial structures remained 2–4 A˚ in the simulations (data not
shown). An exception was the top layer of protoﬁbril 3 that
was partially peeled off from the protoﬁbril, resulting in a
larger RMSD (discussed later). At the end of 20.0 ns, all
phenol red molecules bound to the protoﬁbrils. The systems
were close to steady state, as indicated by the relatively steady
system energy (Fig. 1 C) and number of atom contacts be-
tween four phenol red molecules and protoﬁbril (Fig. 1 A).
Overall, the total energy of the system (Fig. 1 C) dropped
to the steady-state level within 2.0 ns of simulation, whereas
the individual components continued to develop thereafter.
These changes are primarily characterized by the rise of solute-
solvent interaction energy coupled with reduction in both
solvent and solute energies, a hallmark of the desolvation
process. In this process, as solute molecules form closer con-
tacts, water molecules were released from the solute surface
to the bulk of solvent and the number of water molecules in
the ﬁrst two solvation shells are reduced (Fig. 1 B). In fact,
the protoﬁbril-inhibitor complex lost;20% of the water mol-
ecules in the ﬁrst two solvation shells during the process; the
number of water molecules in the ﬁrst solvation shell dropped
to ;400 from initially ;500, and those in the second shell
dropped to;725 from initially;925. The effect is even more
dramatic if one considers that most of the reduction of the
solvation shells was mainly due to desolvation of four phenol
red molecules since the peptides started from the oligomeric
complexes and only surface peptides were marginally sol-
vated. Evidentially, this suggests strongly favorable entropic
and enthalpic contributions upon releasing water molecules
into the bulk solvent.
FIGURE 1 Properties of the protoﬁbril-inhibitor-water system averaged
over all simulations. (Top) Atom contacts between the protoﬁbril and four
phenol red molecules (within 5 A˚ cutoff). (Middle) Number of water
molecules in the ﬁrst (0.0–3.4 A˚) and second (3.4–5.0 A˚) solvation shells of
the solute (the protoﬁbril and the phenol red molecules). (Bottom) The
potential energy changes of the solution, solute, solvent, and the interaction
energy change of solute-solvent upon the binding of the phenol red mole-
cules to the protoﬁbril.
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The enthalpic contribution of the solvent in this binding
process was further evaluated by decomposing the potential
energy of the solution into the potential energies of solute
(protoﬁbril plus phenol red) and solvent (waters) as well as
the solute-solvent interaction energy (Fig. 1 C). Despite the
large ﬂuctuation, the total energy decreased by about ;9.6
kcal/mol when averaged over the ﬁrst and last 4.0 ns. The
solute energy decreased by;53.2 kcal/mol, indicating favor-
able interactions (electrostatic and van der Waal interactions)
between phenol red molecules and the protoﬁbril. In the
meantime, the interaction energies between the solute and
water increased by 80.4 kcal/mol due to desolvation of the
polar groups of both phenol red molecules and the protoﬁbril
upon the binding. Since the phenol red and the protoﬁbril
were well solvated in water before they bound to each other
and their polar groups formed good hydrogen bonds with
water, desolvation effectively removed some of these favor-
able interactions and resulted in large unfavorable water-
solute interaction energy. This unfavorable energy term (80.4
kcal/mol) was compensated partially by the favorable energy
term of phenol red-protoﬁbril interactions (53.2 kcal/mol).
With the favorable water-water interactions (36.7 kcal/mol),
the total potential energy of the system becomes weakly
favorable toward the binding (9.6 kcal/mol). The large fa-
vorable water-water energy (36.7 kcal/mol) demonstrates
the substantial enthalpic contribution from releasing water
molecules to the bulk solvent in the binding process because
of the increased water-water hydrogen bonds formed by the
released water. Other contributions include the favorable
entropy increase by releasing water from the hydrophobic
surface and unfavorable entropy loss due to binding of the
solute molecules.
To illustrate the interactions between phenol red and the
protoﬁbril oligomers, we superimpose the phenol red mol-
ecule images from the simulation snapshots by aligning the
protoﬁbril structures. As shown in Fig. 2, phenol red mole-
cules were bound to the protoﬁbrils and formed tight clusters,
indicating stable binding. Notably, most phenol red mole-
cules were bound to the top or bottom faces of the oligomers
and rarely bound to the peptide main-chain hydrogen bond
face. For protoﬁbril 1 (Fig. 2 A), which is organized as three-
layer ordered b-sheets with each layer a four-strand b-sheet,
the prevalent binding modes were at the top and bottom with
only sporadic binding at the main-chain hydrogen bond
direction. In protoﬁbril 2 (Fig. 2 B) with a similar architec-
ture, there was notable binding at the peptide terminal faces
along the b-strand direction in addition to the binding at the
top and bottom faces. Again, there was virtually no binding
at the b-sheet extension direction along backbone hydrogen
bonds. Therefore, the prevalent mode of binding was at the
b-sheet stacking direction perpendicular to the b-sheet planes.
Incidentally, these protoﬁbril oligomers have comparable
exposed surfaces in all three directions (i.e., b-sheet stacking
direction perpendicular to the b-sheet planes, b-sheet exten-
sion direction along backbone hydrogen bonds, and b-strand
direction). Hence the binding preference observed in the
simulations was an indication of the underlying energetic
bias toward those directions. The lack of interaction with the
main-chain hydrogen bonds is attributable to the physico-
chemical property of phenol red molecules for its lack of
ability to form stable hydrogen bonds with the peptides in
solution.
Clustering analysis is used to illuminate the detailed in-
teractions between phenol red molecules and the protoﬁbril.
In this analysis, the protoﬁbril was ﬁrst aligned and the phenol
red molecules were clustered using the distance between
their geometry centers with a cutoff of 5 A˚. The represen-
tative structures of the top 10 clusters from the combined two
simulation runs of a protoﬁbril are shown in Fig. S3 (Sup-
plementary Material). In addition to the interesting features
noted before, the polar OH and SO3 groups of phenol red
molecules tend to stay in contact with water, indicating they
were still solvated by water molecules upon binding. They
also formed hydrogen bonds with the side chain of Asn and
NH2 of C-termini. In contrast, the apolar aromatic rings of
phenol red molecules tend to cluster around the apolar side
chains. For example, the three rings of phenol red molecule
formed a hydrophobic cluster with the side chains of Leu,
Phe, and Ala in most clusters (e.g., A1, B1, and B3, and
many others). Phenol red molecule was also seen to bind
between the top two layers of the oligomer and formed the
hydrophobic contacts with the side chains of Phe and Ile in
cluster C1. In all these cases, the sulfone group pointed away
from the peptides.
As summarized in Table 2, the phenol red molecules
clustered around the stacking faces of the protoﬁbrils, show-
ing the tendency to bind on the b-sheet surface and, to a less
extent, to the ends of the strands. In fact, the aggregated pop-
ulation of the clusters where phenol red molecules bound to
the protoﬁbrils from the b-sheet stacking and b-strand di-
rections was close to ;60% in the simulations of protoﬁbril
1 and 2 (;64% and;69%, respectively). In comparison, al-
most no phenol red molecule bound to the protoﬁbrils from
the b-sheet extension (hydrogen bond) direction. This may
stem from the geometry of a phenol red molecule which
formed ;200 atom contacts with the side chains and only
;50 with the main chain (data not shown). Since the three
polar groups (two OH groups on the phenol rings and the
SO3 group) of phenol red molecule points to three orthog-
onal directions, it is difﬁcult to simultaneously form three
hydrogen bonds with the peptide main chain. In other words,
due to lack of favorable interactions with peptide main chains
it is less favorable for phenol red molecules to bind to the
protoﬁbrils from the backbone hydrogen bond direction. In
contrast, the size and shape of phenol red molecules are
compatible with the amino acid side chains (e.g., Phe, Leu,
and Ile) and favorable interactions with side chains via
aromatic and/or hydrophobic contacts lead to the binding to
the protoﬁbril preferentially from b-sheet stacking and, to a
lesser degree, b-strand directions.
Phenol Red Binds NFGAIL Protoﬁbrils 3667
Biophysical Journal 91(10) 3664–3672
The polar SO3 and OH groups of phenol red were mostly
solvated in water and formed hydrogen bonds with the
peptides mainly to the NH2 of C-termini and the side chain of
Asn. As shown in Table S1 before binding to the protoﬁbrils
when averaged from the ﬁrst 0.1 ns, the SO3 and the two OH
groups formed, respectively,;3.4 and;4.7 hydrogen bonds
with water molecules that were reduced to, respectively,
;2.4 and ;3.6 when averaged from the last 5 ns. Only
;1 hydrogen bond was lost for each of the SO3 and two OH
groups. Therefore, most of these polar groups were still sol-
vated by water molecules. In contrast, the three aromatic
rings lost ;143 (;40%) atom-atom contacts with water
molecules.
On the other hand, the three aromatic rings of the phenol red
molecule formed ;102 atom-atom contacts with the proto-
ﬁbril, as shown in Table S1, and interacted mostly with the
aromatic and hydrophobic residues and formed aromatic and
hydrophobic clusters with the side chains of Phe, Leu, Ile,
and, to a lesser degree, Ala. In more detail, the rings formed
;20, ;24, and ;23 atom-atom contacts with Phe, Ile, and
Leu, respectively, whereas they formed ;9, ;10, and ;4
atom-atom contacts with Ala, Asn, and Gly, respectively. The
FIGURE 2 Phenol red molecules observed
around the NFGAIL protoﬁbrils. The proto-
ﬁbrils are in cartoon. (Left) Each dot represents
a phenol red molecule conformation. (Right)
Stereoscopic plots of the populated clusters.
Phenol red molecules observed in the simula-
tions are represented by lines.
TABLE 2 Binding of phenol red to protoﬁbrils in different
directions (details are in supplemental Fig. S3)
b-Sheet
stacking direction
(top, down)
b-Strand
direction
(back, front)
b-Sheet extension
direction
(left, right) Others*
Protoﬁbril 1 58% 8% 0% 34%
Protoﬁbril 2 52% 17% 0% 31%
*Sum of all small clusters (population ,2%).
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comparable level of contacts with three hydrophobic residues,
Phe and Leu or Ile, implies that phenol red has a similar
preference toward them. In contrast, the difference between
hydrophobic and hydrophilic contacts indicated that the three
aromatic rings of phenol red interacted mostly with the
aromatic and hydrophobic side chains of Phe, Leu, and Ile.
Therefore, besides aromatic interactions, hydrophobic inter-
actions also played an important role, which is complemen-
tary to the explanation by Gazit and co-workers (14). Thus,
phenol red protects the protoﬁbril oligomers from further
aggregation by interacting with the aromatic and hydrophobic
side chains through its phenol and benzene rings and with
water molecules through its polar sulfone and hydroxyl
groups.
Although protoﬁbril 3 is also organized as a three-layer
b-sheet oligomer, its upper layer consists of only two pep-
tides (Fig. 2 C), rendering it a relatively weaker layer. In the
simulations of protoﬁbril 3, an interesting binding mode was
observed in which the phenol red molecules competed with
the two peptide strands on the top layer for binding to the
middle layer of the oligomer. A result of such competition
was the insertion of phenol red molecules into the area
between the top and middle layers, giving the appearance of
partial removal of the top layer from the protoﬁbril (sup-
plemental Fig. S3 C1). Snapshots from the trajectory are
shown in Fig. 3. In this trajectory, the two b-strands of the
upper layer of the protoﬁbril opened up at ;2.0 ns and two
nearby phenol red molecules moved into the gap and pre-
vented the layer from closing back. At 6.0 ns, the last phenol
red molecule bound to the left edge of the middle layer.
These phenol red molecules stayed at the site throughout the
rest of the simulation. In contrast, in an early study (37)
without phenol red, although the upper layer exhibited ﬂuc-
tuation, it stayed as an integral part of the protoﬁbril in the
last 60 ns till the completion of the 100.0-ns trajectory. Thus,
the fact that the phenol red molecules were able to move into
the gap within 2.0 ns indicates that the phenol red may play a
role in assisting the partial removal of the upper layer by
exploiting weakness of the structure. The fact that insertion
of the phenol red molecules occurred only in one of the six
simulations indicates that such events are rare within the
simulation timescales.
DISCUSSION
The elevated peptide and ligand concentrations in the
simulations in comparison to experimental concentrations
contributed to the signiﬁcant reduction in the computational
cost. At the experimental concentrations (14), we would
have to increase the system size by ;1000 times with a
corresponding increase in computer time. The concentration
also has direct inﬂuence on the kinetic rate of reaction. With
the decrease in concentration by 1000 times, we would ex-
pect an increase in timescales also by 1000 times for the
binding to occur. Thus, the combined increase in computer
time would be ;106 times and the simulations would be in-
tractable. Therefore, we intentionally selected higher concen-
tration to allow simulations to be completed in a reasonable
time. However, because of the increase in concentrations, the
timescales and stability of binding have been changed. Thus,
our study serves to qualitatively characterize the process.
We evaluated the interaction between the protoﬁbrils and
phenol red in basic form that constitutes ;10% in the solu-
tion of pH 6.5. In these calculations, the acidic form phenol
red in the simulated trajectories was substituted by the basic
form and the binding free energy was calculated using the
MM-GBSA method (49). In comparison, the basic form has
a weaker binding free energy (11.3 kcal/mol) than (13.2
kcal/mol) acidic form (Table 3). The difference came from
the unfavorable electrostatic part (;2 kcal/mol) of the bind-
ing free energy, indicating negative charge of the basic form
does not enhance the binding to the hydrophobic peptide. We
like to note that although the MM-GBSA calculations may
overestimate the absolute binding free energy due to the
missing terms (e.g., conformational entropy change of the
solute upon binding) and underestimate the desolvation free
energy, they usually give a reasonable qualitative estimate on
the relative binding free energy when two similar ligands are
compared (50).
In this study, we focused on the interaction between
phenol red molecules and early protoﬁbrils. The majority of
the trajectories indicated that the phenol red molecules bind
to the protoﬁbrils and may prevent formation of larger proto-
ﬁbrils by blocking the hydrophobic surface, disrupting the
surface pattern, and increasing the solubility of small proto-
ﬁbrils. The simulations suggested that the phenol red mol-
ecules interact strongly with the side chains of Phe, Leu, and
Ile through its aromatic phenol and benzene rings. The polar
SO3 and OH groups are mainly exposed to the solvent and
form hydrogen bonds. The result is a highly soluble complex
of protoﬁbril and phenol red molecules. Furthermore, this
effect may be applicable to the nucleation phase of the early
oligomer formation in which peptide monomers undergo
conformation conversion and nucleation. The binding of phe-
nol red molecules to peptide monomers could stabilize the
monomeric peptide and delay/reduce the nucleation. This is
consistent with the observation that chaperones (51) and sur-
factants (52–54) also demonstrate inhibition activity against
amyloid b aggregation.
We shall note that the proposed interaction mechanism of
phenol red deviates somewhat from the initial motivation of
Gazit and co-workers (14), who targeted the aromatic Phe
side chains as the primary binding sites. However, in ad-
dition to the aromaticity, Phe side chains are also very hy-
drophobic. Thus, our results are complementary to the
experimental ﬁndings. Here, our simulation suggests that
phenol red also targets to the hydrophobic nature of Phe. In
addition, it is interesting that phenol red did not bind along
the hydrogen bond direction, indicating interaction at the
b-sheet extension side is not the primary mechanism.
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Further enhancement in binding afﬁnity may be contem-
plated by improving solubility of the aggregates and by
enhancing the interactions with the side chains. Along this
line, we substituted the phenol rings of the phenol red with
the benzene rings to enhance their interactions with the
peptide side chains (Fig. 4 C). Removal of the polar hydroxyl
groups is expected to directly enhance the hydrophobicity of
the two aromatic rings and to indirectly make it easier for
the sulfone group to solvate in water. As a result, this new
compound may have a higher binding afﬁnity to the amyloid
protoﬁbrils. Indeed, the binding free energy of this new com-
pound to the protoﬁbrils was enhanced by 0.9 kcal/mol, as
estimated by the GBSA free energy calculation (Table 3)
with less favorable (5.0 kcal/mol) solvation. This compound
FIGURE 3 Snapshots from a trajectory of protoﬁbril 3.
The three layers of the protoﬁbril are in cartoon. The
phenol red were initially placed 15 and 10 A˚ away from the
protoﬁbril and water-box surface, respectively. For clarity,
water molecules are not shown.
TABLE 3 Binding free energy of phenol red and its analog
Unit (kcal/mol) DEGAS DEGB DESUR DETOT
Phenol red in basic form* 23.8 6 9.0 15.2 6 7.9 2.7 6 0.5 11.3 6 3.3
Phenol red in acidic formy 24.9 6 7 .0 14.4 6 5.2 2.7 6 0.6 13.2 6 3.5
Phenol redz 24.7 14.5 2.7 13.0
Phenol red analog* 20.7 6 5.4 9.4 6 3.3 2.8 6 0.5 14.1 6 3.7
Change (DDE) 4.2 5 0.1 0.9
DEGAS, gas phase potential energy.
DEGB, GB reaction ﬁeld energy.
DESUR, surface area energy.
DETOT ¼ DEGAS 1 DEGB 1 DESUR potential energy in water.
*The representative structures of the populated clusters are shown in supplemental Fig. S3.
yThe complex structures were obtained by substituting the acidic form in supplemental Fig. S3.
z;10% of basic form and ;90% of acidic form at pH ¼ 6.5.
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is commercially available with Chemical Abstract registry
number 15448-98-3. Its solubility in water is reported by
AsInEx (5 Gabrichevskogo St., Bldg. 8, Moscow, 125367) as
113.0764mg/L, which is slightly lower than that of phenol red
(140.1104 mg/L). Taken together, this new compound may
have higher potency to inhibit the amyloid aggregation, ﬁbril
formation, and cytotoxicity.
CONCLUSION
We have conducted a set of simulations to study the in-
teraction between phenol red and the protoﬁbrils of an
amyloidogenic peptide NFGAIL. The favorable binding di-
rection of phenol red molecules to the protoﬁbrils was along
either the b-sheet stacking direction or the b-strand direc-
tion, whereas binding along the b-sheet extension direction
was sporadic. Although multiple binding sites existed, phenol
red molecules mainly interacted with the aromatic and hydro-
phobic side chains of Phe, Leu, Ile, and, to a lesser extent,
Ala through its aromatic rings. Although the sulfone and
hydroxyl groups of phenol red sometimes formed hydrogen
bonds with the amide group of peptide termini Asn and the
blocking unit Nhe, most of the time these polar groups were
exposed to solvent and the effect is an improved solubility of
the aggregate complex. The lack of binding along the
hydrogen-bonding direction suggests that phenol red does
not block b-sheet extension directly. Alternatively, phenol
red may act as a detergent to prevent the formation of larger
protoﬁbrils by the blocking hydrophobic surface and im-
proving the solubility of small peptide aggregates. Based on
the interaction mechanism revealed in the simulations, an
analog is suggested by substituting the phenol rings with
benzene rings that may enhance binding afﬁnity by ;0.9
kcal/mol as calculated using the GBSA method.
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